Uncategorized

Continuous Glucose Monitoring Systems (CGMS) Market is expected to reach $3.6 billion by 2022, growing at a CAGR of 28.2% during 2016-2022

According to a new report, “Global Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)”, published by KBV Research, the Global Continuous Glucose Monitoring Systems Market is expected to reach $3.6 billion by 2022, growing at a CAGR of 28.2% during 2016 -2022.The North America market dominated the Global Continuous Glucose Monitoring Systems Market in 2015, and would grow at a CAGR of 28.1% during the forecast period. However, Asia-Pacific market is expected to grow at CAGR of 32% during 2016-2022.

The Sensors market contributed the larger revenue share to the Global Continuous Glucose Monitoring Systems Market in 2015, and is expected to grow at a CAGR of 31% during the forecast period. The Transmitters & Receivers market is expected attain a market size of $703 million by 2022.

The Diagnostic centers/clinics market registered the largest revenue share in the Global Continuous Glucose Monitoring Systems Market in 2015, and would reach a market size of $1.6 billion by 2022, growing at a CAGR of 27.4% during the forecast period. The Home Healthcare market is expected to grow at CAGR of 42% during 2016-2022.

The report highlights the adoption of Continuous Glucose Monitoring Systems, globally.Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The geographiesincluded in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Full report: https://kbvresearch.com/reportDetail.php?content_id=global-continuous-glucose-monitoring-systems–cgms–market

Research Scope

The market is segmented based on Component, End User and Geography.

Global Continuous Glucose Monitoring Systems Market, by Component

  • Hardware
  • Software
  • Services

Global Continuous Glucose Monitoring Systems Market, by End User

  • Displays Terminals
  • Interface Software
  • Industrial PCs
  • Other Controllers

Global Continuous Glucose Monitoring Systems Market, by Geography

  • North America
    • U.S
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Company Profiles

  • Roche Diagnostics
  • Abbott Laboratories
  • Dexcom Inc.
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
  • Medtronic Plc and
  • Johnson & Johnson
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s